Cognex Corporation (NASDAQ:CGNX – Get Free Report) VP Laura Ann Macdonald sold 14,881 shares of the business’s stock in a transaction on Thursday, February 12th. The stock was sold at an average price of $57.16, for a total value of $850,597.96. Following the completion of the transaction, the vice president directly owned 2,212 shares of the company’s stock, valued at approximately $126,437.92. This trade represents a 87.06% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.
Cognex Stock Up 0.2%
CGNX opened at $58.79 on Monday. The firm has a market cap of $9.74 billion, a P/E ratio of 87.75 and a beta of 1.53. The business’s fifty day simple moving average is $39.44 and its 200 day simple moving average is $41.58. Cognex Corporation has a 52 week low of $22.67 and a 52 week high of $59.88.
Cognex (NASDAQ:CGNX – Get Free Report) last released its earnings results on Wednesday, February 11th. The scientific and technical instruments company reported $0.27 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.22 by $0.05. The company had revenue of $252.34 million for the quarter, compared to analyst estimates of $238.92 million. Cognex had a net margin of 11.51% and a return on equity of 9.02%. The firm’s quarterly revenue was up 9.9% on a year-over-year basis. During the same period in the prior year, the firm earned $0.16 EPS. As a group, equities analysts expect that Cognex Corporation will post 0.61 EPS for the current fiscal year.
Cognex Announces Dividend
Cognex News Summary
Here are the key news stories impacting Cognex this week:
- Positive Sentiment: Q4 earnings beat and revenue growth — Cognex reported $0.27 EPS vs. $0.22 expected and revenue of $252.3M (up ~10% YoY); the stronger-than-expected results and margin improvement were the primary upward catalyst. Earnings Beat
- Positive Sentiment: Raised Q1 guidance — management gave Q1 EPS and revenue guidance above Street estimates (EPS guide 0.220–0.260 vs. consensus ~0.200), supporting the outlook for continued recovery. Guidance & Call
- Positive Sentiment: Analyst upgrade / price target lift — Needham raised its target from $47 to $67 and kept a Buy rating, reinforcing the bullish narrative and adding buy-side momentum. Analyst Raise
- Positive Sentiment: Dividend and shareholder-friendly actions mentioned on the call — Cognex declared a quarterly dividend and discussed portfolio optimization and buyback/dividend moves that support shareholder returns. Dividend & Call Highlights
- Neutral Sentiment: Positive press and commentary — multiple outlets (Seeking Alpha, Motley Fool, Benzinga) published bullish takes on the turnaround and long-term returns; useful for sentiment but reiterative. Feature Article
- Neutral Sentiment: Short interest reporting shows no meaningful short positions in the available data (entries report zero/NaN), so short-squeeze pressure appears unlikely based on current figures.
- Negative Sentiment: Large insider sales — Director Robert Willett sold ~177k shares (~$10.3M) and VP Laura Macdonald sold ~14.9k shares (~$850k). Big insider dispositions can temper sentiment even after strong results. Insider Filings
- Negative Sentiment: Emerging AI regulation risk — Cognex added a regulatory risk disclosure related to rising AI rules that could increase compliance costs and pressure margins over time. AI Regulation Risk
Institutional Trading of Cognex
A number of institutional investors have recently added to or reduced their stakes in CGNX. Northwestern Mutual Wealth Management Co. raised its position in Cognex by 173,138.2% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 10,477,448 shares of the scientific and technical instruments company’s stock valued at $376,979,000 after purchasing an additional 10,471,400 shares during the period. Nordea Investment Management AB grew its stake in shares of Cognex by 148.5% in the second quarter. Nordea Investment Management AB now owns 7,075,772 shares of the scientific and technical instruments company’s stock valued at $223,594,000 after buying an additional 4,228,729 shares in the last quarter. Norges Bank purchased a new stake in shares of Cognex during the 4th quarter valued at about $73,103,000. Alyeska Investment Group L.P. acquired a new position in Cognex during the 4th quarter worth approximately $68,388,000. Finally, AQR Capital Management LLC boosted its holdings in Cognex by 18,810.9% in the 2nd quarter. AQR Capital Management LLC now owns 1,794,649 shares of the scientific and technical instruments company’s stock worth $56,657,000 after acquiring an additional 1,785,159 shares during the period. 88.12% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
Several equities analysts recently commented on the company. Needham & Company LLC upped their target price on Cognex from $47.00 to $67.00 and gave the company a “buy” rating in a research note on Thursday. DA Davidson set a $38.00 price objective on shares of Cognex and gave the company a “neutral” rating in a research note on Monday, November 3rd. The Goldman Sachs Group raised shares of Cognex from a “sell” rating to a “buy” rating and raised their target price for the stock from $42.00 to $50.00 in a research report on Tuesday, December 16th. JPMorgan Chase & Co. reaffirmed an “underweight” rating and set a $35.00 price target (down previously from $45.00) on shares of Cognex in a research report on Wednesday, December 3rd. Finally, Truist Financial cut their price target on shares of Cognex from $45.00 to $42.00 and set a “hold” rating on the stock in a research note on Thursday, December 18th. One analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $50.73.
Check Out Our Latest Research Report on CGNX
About Cognex
Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.
The company’s product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.
Featured Articles
- Five stocks we like better than Cognex
- This $15 Stock Could Go Down as the #1 Stock of 2026
- I’m 70 With $1.5M: Would Converting $120K a Year to a Roth Be Smart or a Costly Mistake? (Ask An Advisor)
- URGENT: Sell this stock immediately
- They just tried to kill gold
- Your Bank Account Is No Longer Safe
Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with MarketBeat.com's FREE daily email newsletter.
